Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WAGENER C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 82

  • Page / 4
Export

Selection :

  • and

Genes in the diagnosis of malignant diseaseWAGENER, C.Annales de biologie clinique (Paris). 1992, Vol 50, Num 4, pp 273-279, issn 0003-3898Article

COMPARATIVE STUDIES ON THE RADIOIMMUNOLOGICAL DETERMINATION OF CARCINOEMBRYONIC ANTIGEN IN TUMOUR TISSUE.WAGENER C; BREUER H.1978; J. CLIN. CHEM. CLIN. BIOCHEM.; DEU; DA. 1978; VOL. 16; NO 6; PP. 323-327; ABS. ALLEM.; BIBL. 18 REF.Article

Molecular diagnosticsWAGENER, C.Journal of molecular medicine (Berlin. Print). 1997, Vol 75, Num 10, pp 728-744, issn 0946-2716Article

DIAGNOSTIC SIGNIFICANCE AND CLINICAL APPLICATION OF TUMOUR-ASSOCIATED ANTIGENS IN MAN WITH SPECIAL REFERENCE TO THE CARCINOEMBRYONIC ANTIGEN.WAGENER C; BREVER H.1977; J. CLIN. CHEM. CLIN. BIOCHEM.; GERM.; DA. 1977; VOL. 15; NO 10; PP. 529-543; ABS. ALLEM.; BIBL. 2 P. 1/2Article

International federation of clinical chemistry : genes in the diagnosis of malignant diseaseWAGENER, C.Clinica chimica acta. 1992, Vol 209, Num 3, pp S15-S26, issn 0009-8981Article

DATEN ZUR VERAENDERUNG DES KLINICHEN BILDES DER LUNGENTUBERKULOSE IN DEN VERGANGENEN 20 JAHREN = DONNEES SUR LA MODIFICATION DU TABLEAU CLINIQUE DE LA TUBERCULOSE PULMONAIRE PENDANT LES 20ANNEES PASSEESWAGENER C; SCHWABE HK.1975; PRAXIS D. PNEUMOL.; DTSCH.; DA. 1975; VOL. 29; NO 3; PP. 135-149; ABS. ANGL.; BIBL. 2P.Article

MONOCLONAL ANTIBODIES FOR CARCINOEMBRYONIC ANTIGEN AND RELATED ANTIGENS AS A MODEL SYSTEM: A SYSTEMATIC APPROACH FOR THE DETERMINATION OF EPITOPE SPECIFICITIES OF MONOCLONAL ANTIBODIES = LES ANTICORPS MONOCLONAUX DE L'ANTIGENE CARCINOEMBRYONNAIRE ET LES ANTIGENES APPARENTES, PRIS COMME SYSTEME MODELE: UNE APPROCHE SYSTEMATIQUE DE LA DETERMINATION DES SPECIFICITES EPITOPIQUES DES ANTICORPS MONOCLONAUXWAGENER C; YANG YHJ; CRAWFORD FG et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 5; PP. 2308-2315; ABS. ENG; BIBL. 31 REF.; GRAPH, FIGArticle

CHARACTERIZATION OF A VARIANT OF CARCINOEMBRYONIC ANTIGEN (CEA) USING MONOCLONAL AND POLYCLONAL ANTI-CEA ANTIBODIESLUKNAR GABOR N; FENGER U; WAGENER C et al.1982; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; ISSN 0006-291X; USA; DA. 1982; VOL. 109; NO 4; PP. 1270-1275; BIBL. 16 REF.Article

LOCALIZATION AND CONCENTRATION OF CARCINOEMBRYONIC ANTIGEN (CEA) IN GASTROINTESTINAL TUMORS: CORRELATION WITH CEA LEVELS IN PLASMAWAGENER C; MUELLER WALLRAF R; NISSON S et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 67; NO 3; PP. 539-547; BIBL. 22 REF.Article

A HIGHLY SENSITIVE METHOD FOR THE DEMONSTRATION OF CARCINOEMBRYONIC ANTIGEN (CEA) IN NORMAL AND NEOPLASTIC COLONIC TISSUEWAGENER C; CZASZAR H; TOTOVIC V et al.1978; HISTOCHEMIST; DEU; DA. 1978; VOL. 58; NO 1-2; PP. 1-11; BIBL. 2 P.Article

LOCALISATION OF CARCINOEMBRYONIC ANTIGEN IN EMBRYONIC AND FETAL HUMAN TISSUESWAGENER C; HAIN F; FODISCH HJ et al.1983; HISTOCHEMISTRY (BERLIN); ISSN 0301-5564; DEU; DA. 1983; VOL. 78; NO 1; PP. 1-9; BIBL. 17 REF.Article

MONOCLONAL ANTIBODIES FOR CARCINOEMBRYONIC ANTIGEN AND RELATED ANTIGENS AS A MODEL SYSTEM: DETERMINATION OF AFFINITIES AND SPECIFICITIES OF MONOCLONAL ANTIBODIES BY USING BIOTIN-LABELED ANTIBODIES AND AVIDIN AS PRECIPITATING AGENT IN A SOLUTION PHASE IMMUNOASSAY = LES ANTICORPS MONOCLONAUX DE L'ANTIGENE CARCINO-EMBRYONNAIRE ET DES ANTIGENES APPARENTES, PRIS COMME SYSTEME MODELE: DETERMINATION DES AFFINITES ET DES SPECIFICITES DES ANTICORPS MONOCLONAUX EN UTILISANT LES ANTICORPS MARQUES A LA BIOTINE ET L'AVIDINE COMME AGENT PRECIPITANT DANS UN DOSAGE IMMUNOLOGIQUE EN PHASE SOLUTIONWAGENER C; CLARK BR; RICKARD KJ et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 5; PP. 2302-2307; ABS. ENG; BIBL. 22 REF.; GRAPHArticle

Structure and genetic engineering of antigens and antibodies : applications in immunoassays = Structure et génie génétique des antigènes et des anticorps: applications aux tests immunologiquesVIHKO, P; WAGENER, C.Annales de biologie clinique (Paris). 1992, Vol 50, Num 8, pp 607-611, issn 0003-3898Article

Structure and genetic engineering of antigens and antibodies : applications in immunoassaysVIHKO, P; WAGENER, C.Clinica chimica acta. 1992, Vol 207, Num 3, pp S5-S11, issn 0009-8981Article

CEA-related CAMsHORST, A. K; WAGENER, C.Handbook of experimental pharmacology. 2004, Vol 165, pp 283-341, issn 0171-2004, 59 p.Article

Activation of the phosphatidylinositol cycle in spreading cellsBREUER, D; WAGENER, C.Experimental cell research. 1989, Vol 182, Num 2, pp 659-663, issn 0014-4827, 5 p.Article

Quantification of carcinoembryonic antigen in serum and analysis of epitope specificities of monoclonal antibodiesWAGENER, C; WICKERT, L; SHIVELY, J. E et al.Methods in enzymology. 1990, Vol 184, pp 507-518, issn 0076-6879, 12 p.Article

Solution-phase RIA and solid-phase EIA using avidin-biotin systems for analysis of monoclonal antibody epitopes and affinity constantsSHIVELY, J. E; WAGENER, C; CLARK, B. R et al.Methods in enzymology. 1986, Vol 121, pp 459-472, issn 0076-6879Article

High background levels compromise the use of cardiac troponin I RNA detection in peripheral blood as a diagnostic tool in cardiologyTSCHENTSCHER, P; HEESCHEN, C; HAMM, C et al.International journal of clinical & laboratory research. 2000, Vol 30, Num 1, pp 13-15, issn 0940-5437Article

Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCRNOLLAU, P; MOSER, C; WEINLAND, G et al.International journal of cancer. 1996, Vol 66, Num 3, pp 332-336, issn 0020-7136Article

Transblot studies with biotin-labeled proteins: electrophoretic mobilities and detection limitsNEUMAIER, M; FENGER, U; WAGENER, C et al.Analytical biochemistry. 1986, Vol 156, Num 1, pp 76-80, issn 0003-2697Article

Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues = Liaison de cinq anticorps monoclonaux anti ACE à différents tissus cancéreux avec diverses spécificités d'épitopesWAGENER, C; PETZOLD, P; KÖHLER, W et al.International journal of cancer. 1984, Vol 33, Num 4, pp 469-475, issn 0020-7136Article

Reversal of RT-PCR inhibition observed in heparinized clinical specimensJUNG, R; LÜBCKE, C; WAGENER, C et al.BioTechniques. 1997, Vol 23, Num 1, pp 24-28, issn 0736-6205, 3 p.Article

Selective precipitation of biotin-labeled antigens or monoclonal antibodies by avidin for determining epitope specificities and affinities in solution-phase assaysWAGENER, C; KRUÊGER, U; SHIVELY, J. E et al.Methods in enzymology. 1990, Vol 184, pp 518-529, issn 0076-6879, 12 p.Article

Limited improvement of tumour diagnosis by the simultaneous determination of carcinoembryonic antigen (CEA) and of a tumour-associated CEA-related antigen of Mr 128000 in serumWAGENER, C; WICKERT, L; MEYERS, W et al.Journal of clinical chemistry and clinical biochemistry. 1989, Vol 27, Num 9, pp 643-652, issn 0340-076X, 10 p.Article

  • Page / 4